Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061600003> ?p ?o ?g. }
- W2061600003 endingPage "508" @default.
- W2061600003 startingPage "497" @default.
- W2061600003 abstract "One-third of all cancer categories in clinics have a high incidence of neoplasm metastasis. Neoplasm metastasis is one of the leading causes of cancer deaths. However, the prevailing therapeutic approach to this pathogenic process is presently unsatisfactory. Paradoxically to our efforts and expectations, except for some antibodies, no obvious improvements and therapeutic benefits in currently used drugs have been achieved until now. Therapeutic benefits in late-stage or elderly cancer patients are especially poor and useless. One of the reasons for this, we would guess, is the lack of therapeutic targets specifically related to neoplasm metastasis. In order to enhance the therapeutic efficacy, the development of antimetastatic drugs transcending from current drug-screening pathways is urgently needed. Antimetastatic drugs targeting aberrantly sialylated in tumors have evolved for about a quarter of a century and might be a future therapeutic option other than the currently utilized antimetastatic drugs, such as antivascular and MMP inhibitors. Since neoplasm tissues often manifest high levels of sialic acids and sialyl antigens or glycoligands, some types of sialic acid analogue, such as N-glycolylneuraminic acid (Nau5Gc), occurred in most tumor tissues which is normally absent in most humans. Consequently, more attention is needed to work with new therapeutic approaches to target these changes. This review addresses and discusses the latest six types of therapeutic approaches targeting sialic acids in metastatic tissues." @default.
- W2061600003 created "2016-06-24" @default.
- W2061600003 creator A5015905956 @default.
- W2061600003 creator A5050106441 @default.
- W2061600003 creator A5069347048 @default.
- W2061600003 date "2012-01-01" @default.
- W2061600003 modified "2023-10-16" @default.
- W2061600003 title "Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids" @default.
- W2061600003 cites W1531203186 @default.
- W2061600003 cites W1705855583 @default.
- W2061600003 cites W1916152252 @default.
- W2061600003 cites W1963592300 @default.
- W2061600003 cites W1971519889 @default.
- W2061600003 cites W1982309126 @default.
- W2061600003 cites W1982704287 @default.
- W2061600003 cites W1988267027 @default.
- W2061600003 cites W1990028811 @default.
- W2061600003 cites W1992848738 @default.
- W2061600003 cites W2001855472 @default.
- W2061600003 cites W2004861464 @default.
- W2061600003 cites W2005034776 @default.
- W2061600003 cites W2007236926 @default.
- W2061600003 cites W2009866496 @default.
- W2061600003 cites W2011307504 @default.
- W2061600003 cites W2020855404 @default.
- W2061600003 cites W2025636448 @default.
- W2061600003 cites W2042637328 @default.
- W2061600003 cites W2063813458 @default.
- W2061600003 cites W2067366222 @default.
- W2061600003 cites W2068602210 @default.
- W2061600003 cites W2070246465 @default.
- W2061600003 cites W2072431766 @default.
- W2061600003 cites W2074516313 @default.
- W2061600003 cites W2079836599 @default.
- W2061600003 cites W2081391345 @default.
- W2061600003 cites W2084857391 @default.
- W2061600003 cites W2091107640 @default.
- W2061600003 cites W2095111363 @default.
- W2061600003 cites W2098602548 @default.
- W2061600003 cites W2102718441 @default.
- W2061600003 cites W2102984786 @default.
- W2061600003 cites W2107160157 @default.
- W2061600003 cites W2108178331 @default.
- W2061600003 cites W2118087421 @default.
- W2061600003 cites W2119924558 @default.
- W2061600003 cites W2123182224 @default.
- W2061600003 cites W2136644692 @default.
- W2061600003 cites W2138348226 @default.
- W2061600003 cites W2150386571 @default.
- W2061600003 cites W2150808054 @default.
- W2061600003 cites W2152359276 @default.
- W2061600003 cites W2161378311 @default.
- W2061600003 cites W2168470451 @default.
- W2061600003 cites W2323894562 @default.
- W2061600003 cites W2335079952 @default.
- W2061600003 cites W2403741171 @default.
- W2061600003 cites W2429497466 @default.
- W2061600003 cites W35175059 @default.
- W2061600003 doi "https://doi.org/10.3797/scipharm.1205-01" @default.
- W2061600003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3447616" @default.
- W2061600003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23008802" @default.
- W2061600003 hasPublicationYear "2012" @default.
- W2061600003 type Work @default.
- W2061600003 sameAs 2061600003 @default.
- W2061600003 citedByCount "20" @default.
- W2061600003 countsByYear W20616000032012 @default.
- W2061600003 countsByYear W20616000032013 @default.
- W2061600003 countsByYear W20616000032014 @default.
- W2061600003 countsByYear W20616000032015 @default.
- W2061600003 countsByYear W20616000032019 @default.
- W2061600003 countsByYear W20616000032020 @default.
- W2061600003 countsByYear W20616000032022 @default.
- W2061600003 countsByYear W20616000032023 @default.
- W2061600003 crossrefType "journal-article" @default.
- W2061600003 hasAuthorship W2061600003A5015905956 @default.
- W2061600003 hasAuthorship W2061600003A5050106441 @default.
- W2061600003 hasAuthorship W2061600003A5069347048 @default.
- W2061600003 hasBestOaLocation W20616000031 @default.
- W2061600003 hasConcept C121608353 @default.
- W2061600003 hasConcept C126322002 @default.
- W2061600003 hasConcept C142724271 @default.
- W2061600003 hasConcept C19831878 @default.
- W2061600003 hasConcept C2778384578 @default.
- W2061600003 hasConcept C2779013556 @default.
- W2061600003 hasConcept C2779134260 @default.
- W2061600003 hasConcept C2780035454 @default.
- W2061600003 hasConcept C2780115458 @default.
- W2061600003 hasConcept C2780635560 @default.
- W2061600003 hasConcept C502942594 @default.
- W2061600003 hasConcept C54355233 @default.
- W2061600003 hasConcept C71924100 @default.
- W2061600003 hasConcept C86803240 @default.
- W2061600003 hasConcept C98274493 @default.
- W2061600003 hasConceptScore W2061600003C121608353 @default.
- W2061600003 hasConceptScore W2061600003C126322002 @default.
- W2061600003 hasConceptScore W2061600003C142724271 @default.
- W2061600003 hasConceptScore W2061600003C19831878 @default.
- W2061600003 hasConceptScore W2061600003C2778384578 @default.